Betahistine
Brand names: Serc
Betahistine is an oral histamine analogue used to reduce the frequency and severity of vertigo, tinnitus and hearing loss associated with Meniere's disease; this page concerns its use in older patients.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It acts as a histamine H1 agonist and H3 antagonist, thought to improve microcirculation in the inner ear (stria vascularis) and modulate vestibular activity, reducing endolymphatic pressure.
Prescribing in practice
- In older patients caution applies in active or past peptic ulcer disease and in asthma, as betahistine may aggravate these conditions.
- It is best taken with food to reduce gastrointestinal upset.
- Benefit on Meniere's symptoms is modest and variable, so review effectiveness and avoid attributing all balance problems in older people to a single cause.
Monitoring
Monitor clinically for change in vertigo frequency and severity and for gastrointestinal or respiratory adverse effects.
Counselling the patient
- Take it with or after food.
- Report worsening indigestion, stomach pain or wheeze.
- Effects build over time and the medicine controls rather than cures symptoms.
Evidence & guidelines
Evidence for symptom benefit in Meniere's disease is limited and mixed, and use reflects the product SPC and specialist practice rather than a definitive landmark trial.
Reference: NICE Evidence Review (Betahistine for Meniere's); Cochrane Review (betahistine); BSA Meniere's guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5